Answers are grounded in this paper and cite their sources.
Neurologic complications significantly contribute to the morbidity and mortality of patients receiving allogeneic BMT. Subclinical abnormalities, cognitive deficits, and white matter lesions detected 1 year after BMT in a subgroup of patients may be related to more extensive CNS changes observed after transplantation in an earlier retrospective study and may be associated with the risk factor chronic GvHD/immunosuppression.
No takes yet. Share an insight, caveat, or question.
Sostak et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: